Table II.
Patient and Observer Scar Assessment Scale assessment from baseline to all follow-ups
| Laser+steroid Mean±SD | Laser+petrolatum Mean ± SD | 95% CI of the difference | p-value between segment | |
|---|---|---|---|---|
| Observer portion | ||||
| Baseline | 32.53± 6.43 | 32.03 ± 5.23 | –1.27–2.27 | 0.561 |
| 2 weeks after 2nd treatment | 25.79± 5.46 | 27.05 ± 4.56 | –2.98–0.46 | 0.140 |
| 1 week after 4th treatment | 21.45± 6.25 | 23.03 ± 5.57 | –3.28–0.12 | 0.067 |
| 1-month follow-up | 22.00± 6.56 | 22.71 ± 5.90 | –2.33–0.91 | 0.369 |
| 3-month follow-up | 21.79± 5.15 | 22.82 ± 4.02 | –2.57–0.52 | 0.181 |
| 6-month follow-up | 20.42± 5.08 | 21.97 ± 4.50 | –3.39–0.28 | 0.092 |
| p-value between visit | < 0.001 | < 0.001 | Not applicable | |
| Patient portion | ||||
| Baseline | 28.26± 7.17 | 28.63 ± 7.21 | –2.97–2.23 | 0.769 |
| 2 weeks after 2nd treatment | 19.05± 6.24 | 19.26 ± 7.16 | –2.83–2.41 | 0.868 |
| 1 week after 4th treatment | 19.68± 7.63 | 19.37 ± 7.14 | –2.18–2.81 | 0.793 |
| 1-month follow-up | 17.00± 5.54 | 17.74 ± 5.80 | –3.50–2.03 | 0.583 |
| 3-month follow-up | 17.63± 6.45 | 18.37 ± 6.91 | –4.14–2.67 | 0.655 |
| 6-month follow-up | 17.47± 6.07 | 18.32 ± 4.97 | –3.70–2.02 | 0.544 |
| p-value between visit | < 0.001 | 0.001 | Not applicable | |
CI: confidence interval.